Lifeboat Foundation

After joining a Mayo Clinic trial, Lee Mercker is recovering well—thanks to a shot.

Many purposes underlie all the genetic projects of our day. Are you aware of them?

“What foundational values need to be in place for an ethical utilitronium shockwave?”

What foundational values need to be in place for an ethical utilitronium shockwave?
We discuss:
- (following on from a previous video) more on Nozick’s experience machines (see https://www.youtube.com/watch?v=CxBvNbuYud0).
- given that in each age there has been different conceptions of utopia, what would utopia be for a post-human superintelligence?
- classical utilitarian vs negative utilitarian approaches to the long term good of life in the universe.
- whether a perfect decision theory would be equal to negative utilitarianism.
- how much attention should we give to preferences in improving well-being beyond eliminating suffering?
- if one does believe in the objectivity of value should we be concerned about being damned in a local maximum of well-being?
- what is God’s utility function?

Continue reading “David Pearce — Foundational Values for the Future — What is God’s Utility Function?” »

ROCHESTER, Minn. — A Mayo Clinic study finds that applying artificial intelligence (AI) to a widely available, inexpensive test – the electrocardiogram (EKG) – results in a simple, affordable early indicator of asymptomatic left ventricular dysfunction, which is a precursor to heart failure. The research team found that the AI/EKG test accuracy compares favorably with other common screening tests, such as mammography for breast cancer. The findings were published in Nature Medicine.

Asymptomatic left ventricular dysfunction is characterized by the presence of a weak heart pump with a risk of overt heart failure. It affects 7 million Americans, and is associated with reduced quality of life and longevity. But asymptomatic left ventricular dysfunction is treatable when identified.

UPS Flight Forward recently was awarded their Part 135 certification from the Federal Aviation Administration, which allows them to make deliveries by drone throughout the U.S. This week, UPS in partnership with CVS made their first residential delivery by drone by dropping off prescription drugs from a CVS pharmacy directly to a consumer’s home.

The Kidney Project, a national effort to develop an implantable bio-artificial kidney that could eliminate the need for dialysis, will announce a key milestone in a November 7, 2019 presentation at the American Society of Nephrology Kidney Week 2019 conference in Washington, DC.

The team will report that UC San Francisco scientists have successfully implanted a prototype kidney bioreactor containing functional human kidney cells into pigs without significant safety concerns. The device, which is about the size of a deck of cards, did not trigger an immune reaction or cause blood clots in the animals, an important milestone on the road to future human trials.

“This is the first demonstration that kidney cells can be implanted successfully in a large animal without immunosuppression and remain healthy enough to perform their function. This is a key milestone for us,” said Kidney Project co-lead Shuvo Roy, Ph.D., a faculty member in the Department of Bioengineering and Therapeutic Sciences, a joint department of the UCSF Schools of Pharmacy and Medicine. “Based on these results, we can now focus on scaling up the bioreactor and combining it with the blood filtration component of the artificial kidney.”

While many high-school sophomores are busy partying and socializing, Jack Andraka developed a test for pancreatic cancer that is the first test that detects the disease and tumors before they get out of hand.

And with pancreatic cancer having the lowest survival rate of any cancer, he truly accomplished something amazing with his work.

Continue reading “15-Year-Old Creates Cancer Test That Is 26,000 Times Less Expensive With 100% Accuracy” »

Questionable startups are claiming to be able to determine how smart a frozen IVF embryo will become if carried to term, and parents are taking the bait.

Genomic Prediction, the most prominent of these companies, offers tests to scan embryos for genetic diseases and other conditions — as well as genetic indicators that a future child will be in the bottom two percent of intelligence.

And MIT Technology Review reports that Genomic Prediction co-founder Stephen Hsu often uses media appearances to discuss future plans for a general intelligence test — something that, with current tech, is extremely unlikely to actually work.

ROCKVILLE, Md. (WJZ) — A Maryland medical company has submitted an application to the U.S Food and Drug Administration for a gene therapy it says will eliminate HIV.

American Gene Technologies in Rockville said based on lab tests, the single-dose gene therapy has a “high potential” to be effective.